Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, March 18, 2014

Jordan Schwartz on Novartis Trying to Buy Israeli Stem Cell Research Developer

The Novartis dug company is in advanced talks to buy up Israeli-based stem cell treatments developer Gamida-Cell for $600 million, sources told the Globes business newspaper.

http://ift.tt/1gD76Dx

No comments:

Post a Comment

Popular Stem Cell Roundup Posts